Abstract
Opioid peptides showing selectivity for d receptor have been isolated from enzymatic digests of plant proteins. Five peptides were derived from wheat gluten, and named gluten exorphins A5, A4, B5, B4 and C. Two opioid peptides were also released from spinach ribulosebisphosphate- carboxylase / oxygenase (Rubisco), and named rubiscolins-5 and -6. Among them, gluten exorphin 5A (Gly-Tyr-Tyr-Pro-Thr) and rubiscolin-6 (Tyr-Pro-Leu-Asp-Leu-Phe) improved learning performance in step-through type passive avoidance test after post-training oral administration in mice at doses of 300 mg / kg and 100 mg / kg, respectively, which are smaller than those required for antinociceptive activity.
Keywords: opioid peptide, gluten exorphin, rubisco, antinociception, learning, memory, anxiolytic, antidepressant
Current Pharmaceutical Design
Title: Delta Opioid Peptides Derived from Plant Proteins
Volume: 9 Issue: 16
Author(s): M. Yoshikawa, M. Takahashi and S. Yang
Affiliation:
Keywords: opioid peptide, gluten exorphin, rubisco, antinociception, learning, memory, anxiolytic, antidepressant
Abstract: Opioid peptides showing selectivity for d receptor have been isolated from enzymatic digests of plant proteins. Five peptides were derived from wheat gluten, and named gluten exorphins A5, A4, B5, B4 and C. Two opioid peptides were also released from spinach ribulosebisphosphate- carboxylase / oxygenase (Rubisco), and named rubiscolins-5 and -6. Among them, gluten exorphin 5A (Gly-Tyr-Tyr-Pro-Thr) and rubiscolin-6 (Tyr-Pro-Leu-Asp-Leu-Phe) improved learning performance in step-through type passive avoidance test after post-training oral administration in mice at doses of 300 mg / kg and 100 mg / kg, respectively, which are smaller than those required for antinociceptive activity.
Export Options
About this article
Cite this article as:
Yoshikawa M., Takahashi M. and Yang S., Delta Opioid Peptides Derived from Plant Proteins, Current Pharmaceutical Design 2003; 9 (16) . https://dx.doi.org/10.2174/1381612033454838
DOI https://dx.doi.org/10.2174/1381612033454838 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson’s Disease
Current Genomics Adaptive Behavior in Williams-Beuren Syndrome, Down Syndrome, and Autism Spectrum Disorder
Current Psychiatry Reviews Prolactin and Blood-Brain Barrier Permeability
Current Neurovascular Research Cyclin D1 Gene Silencing by siRNA in Ex Vivo Human Tissue Cultures
Current Drug Delivery Modulation of Cardiovascular Remodeling with Statins: Fact or Fiction?
Current Vascular Pharmacology Season of Birth Effects on Reproduction in Women
Current Women`s Health Reviews Simultaneous Detection of Dopamine and Serotonin in Real Complex Matrices
Current Analytical Chemistry Noscapine-loaded PLA Nanoparticles: Systematic Study of Effect of Formulation and Process Variables on Particle Size, Drug Loading and Entrapment Efficiency
Pharmaceutical Nanotechnology Implication of Oncogenic Signaling Pathways as a Treatment Strategy for Neurodegenerative Disorders – Contemporary Approaches
CNS & Neurological Disorders - Drug Targets Editorial [Hot topic:Food Addiction & Obesity Treatment Development (Executive Guest Editors: Mark S. Gold and Noni A. Graham)]
Current Pharmaceutical Design Ligand Based Validated Comparative Chemometric Modeling and Pharmacophore Mapping of Aurone Derivatives as Antimalarial Agents
Current Computer-Aided Drug Design Aging and Autism: Understanding, Intervention and Proposals to Improve Quality of Life
Current Pharmaceutical Design The CCL2/CCR2 Axis in the Pathogenesis of HIV-1 Infection: A New Cellular Target for Therapy?
Current Drug Targets β-Sheet Breakers for Alzheimers Disease Therapy
Current Drug Targets Melatonin Effects on Plasmodium Life Cycle: New Avenues for Therapeutic Approach
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) A Review on Defects of Dendritic Cells in Common Variable Immunodeficiency
Endocrine, Metabolic & Immune Disorders - Drug Targets Investigation of the Biological Activities of Different Extracts from Dipsacus laciniatus Aerial Parts
The Natural Products Journal HIV: A Raft-Targeting Approach for Prevention and Therapy Using Plant-Derived Compounds (Review)
Current Drug Targets Basic Mechanisms Involved in the Anti-Cancer Effects of Melatonin
Current Medicinal Chemistry Microwaves-Assisted Syntheses of Imidazolylbenzamides and their Antioxidant Activities
Letters in Drug Design & Discovery